BACKGROUND: The T(peak)T(end) (T(p)T(e)) interval is believed to reflect the transmural dispersion of repolarization. Accordingly, it should be a risk factor in long QT syndrome (LQTS). The aim of the study was to determine the effect of genotype on T(p)T(e) interval and test whether it was related to the occurrence of syncope. METHODS: Electrocardiograms were taken in 95 patients with LQTS drawn from the Danish long QT registry (44 patients with KvLQT1, 43 with HERG, and 8 with SCN5A mutations) and manually evaluated for the QT, QT(peak), and RR interval. RESULTS AND CONCLUSION: (1) T(p)T(e) cannot be used to distinguish symptomatic from asymptomatic patients with LQTS; (2) HERG patients have longer T(p)T(e) than KvLQT1 patients; and (3) there is no need to heart rate-correct T(p)T(e) intervals in patients with LQTS.
BACKGROUND: The T(peak)T(end) (T(p)T(e)) interval is believed to reflect the transmural dispersion of repolarization. Accordingly, it should be a risk factor in long QT syndrome (LQTS). The aim of the study was to determine the effect of genotype on T(p)T(e) interval and test whether it was related to the occurrence of syncope. METHODS: Electrocardiograms were taken in 95 patients with LQTS drawn from the Danish long QT registry (44 patients with KvLQT1, 43 with HERG, and 8 with SCN5A mutations) and manually evaluated for the QT, QT(peak), and RR interval. RESULTS AND CONCLUSION: (1) T(p)T(e) cannot be used to distinguish symptomatic from asymptomatic patients with LQTS; (2) HERGpatients have longer T(p)T(e) than KvLQT1patients; and (3) there is no need to heart rate-correct T(p)T(e) intervals in patients with LQTS.
Authors: Tanveer A Bhuiyan; Claus Graff; Jørgen K Kanters; Jimmi Nielsen; Jacob Melgaard; Jørgen Matz; Egon Toft; Johannes J Struijk Journal: Clin Drug Investig Date: 2015-11 Impact factor: 2.859
Authors: Pentti M Rautaharju; Zhu-ming Zhang; Richard E Gregg; Wesley K Haisty; Mara Z Vitolins; Anne B Curtis; James Warren; Milan B Horaĉek; Sophia H Zhou; Elsayed Z Soliman Journal: J Electrocardiol Date: 2013-07-01 Impact factor: 1.438
Authors: Jimmi Nielsen; Claus Graff; Jørgen K Kanters; Egon Toft; David Taylor; Jonathan M Meyer Journal: CNS Drugs Date: 2011-06-01 Impact factor: 5.749
Authors: Kapuaola S Gellert; Pentti Rautaharju; Michelle L Snyder; Eric A Whitsel; Kunihiro Matsushita; Gerardo Heiss; Elsayed Z Soliman Journal: J Electrocardiol Date: 2014-03-06 Impact factor: 1.438
Authors: Claus Graff; Mads P Andersen; Joel Q Xue; Thomas B Hardahl; Jørgen K Kanters; Egon Toft; Michael Christiansen; Henrik K Jensen; Johannes J Struijk Journal: Drug Saf Date: 2009 Impact factor: 5.606